Literature DB >> 9585121

Central distribution and function of 5-HT6 receptor subtype in the rat brain.

M Yoshioka1, M Matsumoto, H Togashi, K Mori, H Saito.   

Abstract

The purpose of the present study was to elucidate the distribution of 5-HT6 receptor mRNA and possible physiological functions of the 5-HT6 receptor subtype using antisense oligonucleotides (AOs) in rats. Continuous intracerebroventricular injection of AOs caused a 30% reduction in the number of [3H]-lysergic acid diethylamide binding sites. Conditioned fear stress-induced increase in 5-HT release from the prefrontal cortex was significantly inhibited by treatment with AOs. The present study suggests that 5-HT6 receptors may be functionally expressed in the brain, where one of the functions appears to be in the mediation of certain anxiety disorders.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9585121     DOI: 10.1016/s0024-3205(98)00092-7

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  12 in total

1.  Characterization of SB-271046: a potent, selective and orally active 5-HT(6) receptor antagonist.

Authors:  C Routledge; S M Bromidge; S F Moss; G W Price; W Hirst; H Newman; G Riley; T Gager; T Stean; N Upton; S E Clarke; A M Brown; D N Middlemiss
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

2.  Distribution of serotonin receptor of type 6 (5-HT₆) in human brain post-mortem. A pharmacology, autoradiography and immunohistochemistry study.

Authors:  Donatella Marazziti; Stefano Baroni; Andrea Pirone; Gino Giannaccini; Laura Betti; Lara Schmid; Elena Vatteroni; Lionella Palego; Franco Borsini; Fabio Bordi; Ilaria Piano; Claudia Gargini; Maura Castagna; Mario Catena-Dell'osso; Antonio Lucacchini
Journal:  Neurochem Res       Date:  2012-01-26       Impact factor: 3.996

3.  Characterization of [(125)I]-SB-258585 binding to human recombinant and native 5-HT(6) receptors in rat, pig and human brain tissue.

Authors:  W D Hirst; J A Minton; S M Bromidge; S F Moss; A J Latter; G Riley; C Routledge; D N Middlemiss; G W Price
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

4.  Pro-cognitive effects of 5-HT6 receptor antagonists in the social recognition procedure in rats: implication of the frontal cortex.

Authors:  Florence Loiseau; Anne Dekeyne; Mark J Millan
Journal:  Psychopharmacology (Berl)       Date:  2007-10-06       Impact factor: 4.530

5.  5-HT6 Receptor Recruitment of mTOR Modulates Seizure Activity in Epilepsy.

Authors:  Liang Wang; Yaodong Lv; Wanni Deng; Xi Peng; Zheng Xiao; Zhiqin Xi; Guojun Chen; Xuefeng Wang
Journal:  Mol Neurobiol       Date:  2014-07-18       Impact factor: 5.590

6.  Reversal of a cholinergic-induced deficit in a rodent model of recognition memory by the selective 5-HT6 receptor antagonist, Ro 04-6790.

Authors:  Marie L Woolley; Charles A Marsden; Andrew J Sleight; Kevin C F Fone
Journal:  Psychopharmacology (Berl)       Date:  2003-09-10       Impact factor: 4.530

7.  Ro 04-6790-induced cognitive enhancement: no effect in trace conditioning and novel object recognition procedures in adult male Wistar rats.

Authors:  K E Thur; A J D Nelson; H J Cassaday
Journal:  Pharmacol Biochem Behav       Date:  2014-10-24       Impact factor: 3.533

8.  Candidate genes for antidepressant response to selective serotonin reuptake inhibitors.

Authors:  Francis E Lotrich; Bruce G Pollock
Journal:  Neuropsychiatr Dis Treat       Date:  2005-03       Impact factor: 2.570

9.  Study on the effect of EMD386088, a 5-HT6 receptor partial agonist, in enhancing the anti-immobility action of some antidepressants in rats.

Authors:  Magdalena Jastrzębska-Więsek; Agata Siwek; Anna Partyka; Marcin Kołaczkowski; Maria Walczak; Magdalena Smolik; Gniewomir Latacz; Katarzyna Kieć-Kononowicz; Anna Wesołowska
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-10-27       Impact factor: 3.000

10.  Dysregulation of 5-hydroxytryptamine 6 receptor accelerates maturation of bone-resorbing osteoclasts and induces bone loss.

Authors:  Kyung-Ran Park; Eun-Cheol Kim; Jin Tae Hong; Hyung-Mun Yun
Journal:  Theranostics       Date:  2018-04-30       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.